New experiments under Article 51 of the Social Security Financing Act in February 2026 in France

Article 51 of the Social Security Financing Act enables the funding of innovative organizational models in healthcare and the technologies that support their implementation. To qualify for funding under this framework, proposed experiments must aim to improve access to healthcare, system efficiency, the appropriateness of prescriptions, and the patient care pathway. This approach allows such experiments to bypass certain provisions of social security financing regulations, particularly those related to the coordination of care pathways, the relevance and quality of health, social, or medico-social services, the organization of ambulatory care, and access to healthcare.

The French Ministry of Health, Family, Autonomy, and People with Disabilities constantly announces the new experiments initiated under Article 51 of the Social Security Financing Act. 

In February 2026, three new experiments were announced:

• “ADELE: Caregivers in the stages of the evolution of the care pathway,” with the total financing at €402,000 for two years (national);
• “AUTO-NOM 2 - Mobile Neuro-Orthopedics,” with the total financing estimated at €3,431,801 for three years (national);
• “PREVENIR 2.0: Early detection and prevention of chronic kidney disease,” with the total financing estimated at €695,382 for four years (local).

The full details in French can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.